Blood test could spot cancer return before scans
NCT ID NCT02842203
Summary
This study is testing a new blood test to see if it can detect the return of stage III colon or rectal cancer earlier than current methods. Researchers are following 137 patients for up to 5 years, collecting blood samples regularly to look for tiny pieces of cancer DNA. The goal is to learn if this test can better predict a patient's outcome and monitor for recurrence compared to the standard blood test used today.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE III COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, 15232, United States
Conditions
Explore the condition pages connected to this study.